Glassia is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin deficiency, a rare genetic condition. Glassia is also known by its drug name, alpha1-proteinase inhibitor [human].

Glassia is an alpha1-proteinase inhibitor, a type of molecule derived from human plasma. Glassia is believed to work by protecting the lungs from damage.

How do I take it?
Glassia is administered once a week as an intravenous infusion.

Glassia comes in the form of a single-use vial.

Side effects
The FDA-approved label for Glassia lists common side effects... read more

Glassia (Alpha1-proteinase inhibitor [human]) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in